Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,685 INR | +2.19% | +8.57% | +41.52% |
Chart calendar GlaxoSmithKline Pharmaceuticals Limited
Upcoming events on GlaxoSmithKline Pharmaceuticals Limited
Past events on GlaxoSmithKline Pharmaceuticals Limited
31/05/2024 | Détachement de for final dividend |
17/05/2024 01:58 pm | Q4 2024 Earnings Release |
17/05/2024 | Investor Meeting |
15/02/2024 04:00 pm | Investor Meeting |
12/02/2024 04:55 pm | Q3 2024 Earnings Release |
24/11/2023 | Investor Meeting |
09/11/2023 04:35 pm | Q2 2024 Earnings Release |
17/08/2023 | Analyst Meeting - Birla Sunlife MF |
26/07/2023 02:30 pm | Annual General Meeting |
26/07/2023 01:45 pm | Q1 2024 Earnings Release |
30/06/2023 | Détachement de for final dividend |
09/06/2023 | Investor Meeting - HDFC Life Insurance Company Limited |
09/06/2023 | Investor Meeting - Investor Meeting Mutual Fund |
17/05/2023 04:53 pm | Q4 2023 Earnings Release |
16/03/2023 04:30 pm | Investor Meeting |
07/02/2023 04:10 pm | Q3 2023 Earnings Release |
11/11/2022 04:08 pm | Interim 2023 Earnings Release |
23/08/2022 04:00 pm | Analyst Meeting |
26/07/2022 01:30 pm | Annual General Meeting |
25/07/2022 08:14 pm | Q1 2023 Earnings Release |
Past dividends on GlaxoSmithKline Pharmaceuticals Limited
31/05/2024 | Annual 32 INR |
30/06/2023 | Annual 32 INR |
07/07/2022 | Annual 30 INR |
07/07/2022 | Bonus Payment 60 INR |
19/07/2021 | Annual 30 INR |
17/07/2020 | Annual 20 INR |
17/07/2020 | Bonus Payment 20 INR |
11/07/2019 | Annual 20 INR |
13/07/2018 | Annual 35 INR |
14/07/2017 | Annual 30 INR |
Annual results
Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 32 244 32 844 -1.83% | 31 989 32 599 -1.87% | 32 780 34 314 -4.47% | 32 517 33 026 -1.54% | 34 537 33 649 2.64% | 37 987 |
EBITDA Million INR | Released Forecast Spread | 6 573 6 522 0.77% | 6 953 7 174 -3.08% | 8 273 8 140 1.64% | 8 043 8 279 -2.85% | 9 087 8 671 4.8% | 10 579 |
EBIT Million INR | Released Forecast Spread | 5 746 6 114 -6.02% | 6 161 6 667 -7.59% | 7 592 7 506 1.14% | 7 385 7 769 -4.93% | 8 390 8 450 -0.71% | 10 191 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 3 058 2 898 5.5% | 5 505 7 095 -22.41% | 7 791 13 406 -41.89% | 8 364 8 191 2.11% | 8 162 9 325 -12.47% | 11 084 |
Net income Million INR | Released Forecast Spread | 932 858 8.6% | 3 582 5 195 -31.05% | 16 947 11 084 52.9% | 6 107 6 224 -1.88% | 5 900 6 063 -2.7% | 8 176 |
EPS INR | Released Forecast Spread | 5,50 14,6 -62.37% | 21,1 30,9 -31.65% | 100 61,9 61.62% | 36,1 37,1 -2.82% | 34,8 40,2 -13.36% | 48,3 |
Announcement Date | 18/05/20 | 18/05/21 | 16/05/22 | 17/05/23 | 17/05/24 | - |
Quarterly results
Fiscal Period | March | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 8 096 8 734 -7.3% | 7 451 8 412 -11.43% | 9 169 9 802 -6.46% | 8 023 8 681 -7.58% | 7 875 8 176 -3.69% | 7 617 7 662 -0.6% | 9 570 9 129 4.83% | 8 053 8 555 -5.87% | 9 298 8 396 10.74% |
EBITDA Million INR | Released Forecast Spread | 1 752 1 990 -11.96% | 1 489 1 857 -19.82% | 2 569 2 429 5.76% | 2 287 2 264 1.01% | 1 697 1 863 -8.89% | 1 439 1 647 -12.65% | 2 895 2 351 23.12% | 2 181 2 354 -7.37% | 2 573 2 098 22.64% |
EBIT Million INR | Released Forecast Spread | 1 599 1 998 -19.98% | 1 331 1 770 -24.8% | 2 406 2 323 3.56% | 2 123 1 926 10.22% | 1 526 2 291 -33.41% | 1 275 1 764 -27.71% | 2 714 2 339 16.02% | 2 010 2 049 -1.93% | 2 392 1 898 26.01% |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 2 079 2 065 0.65% | 1 600 1 919 -16.61% | 2 622 2 480 5.71% | 2 243 2 116 5.98% | 1 900 2 437 -22.05% | 1 810 1 991 -9.1% | 2 992 2 701 10.76% | 654 2 327 -71.88% | 2 706 2 168 24.82% |
Net income Million INR | Released Forecast Spread | 12 191 1 672 629.1% | 1 193 1 523 -21.68% | 1 934 1 908 1.4% | 1 646 1 648 -0.17% | 1 334 1 383 -3.49% | 1 323 1 202 10.02% | 2 175 1 998 8.86% | 457 1 295 -64.68% | 1 945 1 610 20.8% |
EPS INR | Released Forecast Spread | 72,0 10,3 596.61% | 7,04 9,30 -24.3% | 11,4 10,1 12.62% | 9,71 10,0 -3.33% | 7,88 11,3 -30.2% | ||||
Announcement Date | 16/05/22 | 25/07/22 | 11/11/22 | 07/02/23 | 17/05/23 | 26/07/23 | 09/11/23 | 12/02/24 | 17/05/24 |
Past sector events for GlaxoSmithKline Pharmaceuticals Limited
07/06/2024 04:03 pm | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
07/06/2024 02:47 pm | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
30/05/2024 05:38 pm | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
30/05/2024 11:54 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
29/05/2024 05:30 pm | FDC LIMITED: Q4 2024 Earnings Release |
29/05/2024 02:56 pm | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
29/05/2024 02:14 pm | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
29/05/2024 01:40 pm | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
29/05/2024 | PFIZER LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLAXO Stock
- Calendar GlaxoSmithKline Pharmaceuticals Limited